MEDINET Co., Ltd. (2370)

Market cap
¥7.9B
P/E ratio
-5.5x
Medinet develops cell processing and regenerative medicine products for hospitals and pharmaceutical companies, offering manufacturing services and facility operations.
Period EndCost of revenue (Million JPY)YoY (%)
Sep 30, 2025701+6.83%
Sep 30, 2024656+16.42%
Sep 30, 2023563+11.38%
Sep 30, 2022506+0.62%
Sep 30, 2021503+2.23%
Sep 30, 2020492-25.35%
Sep 30, 2019659-1.45%
Sep 30, 2018668-28.52%
Sep 30, 2017935-10.85%
Sep 30, 20161,049+4.72%
Sep 30, 20151,001-1.67%
Sep 30, 20141,018
AI Chat